Start 30 days free, no card. Full Pro access for a month, then decide. Start free
Analyst
Pallav Mittal
Period: Reporting periods mapped to calendar 2025 Q4 – 2026 Q2 (3 quarters).
- Questions
- 9on tracked calls
- Challenge rate
- 22%2 of 9 questionsLimited sample
- Companies
- 3questioned at least once
- Reporting periods
- 3with questions
These figures cover the whole profile: every tracked question, all reporting periods.
How to read these numbers
Challenge rate is the share of questions that pushed back, pressed for specifics or questioned management’s assumptions. It describes how questions were asked on the calls tracked here; it does not measure whether any view turned out to be right.
Rounding. Rates are rounded to whole percentages, so a small share can show as 0% even when some questions were challenging. The count beside each rate is exact; “none of N questions” means no question was challenging.
No questions recorded. “—” means there is nothing to calculate: no questions were recorded for that period on the calls tracked here. It does not mean there was no activity.
Fewer than 3 questions. A company-level rate is withheld when fewer than 3 questions were recorded for that company; the questions are still counted everywhere else.
Small samples. Profiles with fewer than 10 questions are marked Limited sample.
Reporting periods. Questions are grouped by the calendar quarter each company’s fiscal reporting period maps to, not by the date of the call. Periods without a calendar mapping are listed separately under their fiscal label.
Questions asked
Grouped by company, most questions first. Open a company to read its questions, newest reporting period first.
Showing 9 of 9 questions from 3 companies
MOAltria4 questions · 2 reporting periods · 1 of 4 challenging
Calendar 2026 Q2
are you seeing any impact from higher gas prices because even Q2 volumes were strong?
Show response
Gave the specific elasticity coefficient and attributed PM USA's volume outperformance to the total portfolio approach.
despite the national expansion, volumes haven't accelerated significantly. So just wanted to check if there is any
Show response
Confirmed the comp issue explicitly, prior-year promotional activity plus Q1/Q2 timing ahead of the on! PLUS national launch.
Calendar 2025 Q4
why are you starting with just three states and not go out national from the start
Show response
Billy explained three-state start was practical, salesforce had existing relationships there. National expansion is in progress for 2026.
that is not what I think the scanner data is suggesting. And it seems pricing is rather up for the larger players
Show response
Billy clarified the -3% sequential/-12% YoY is all competitors combined. A major competitor distributed free cans for any nicotine purchase, significantly impacting competitive pricing. on! Classic prices were up.
PMPhilip Morris International4 questions · 2 reporting periods · 1 of 4 challenging
Calendar 2026 Q2
What gives you the confidence that IQOS IMS can accelerate again in Europe?
Show response
Andolina pointed to prior flavor-ban recoveries, a broadened portfolio (DELIA, LEVIA), and the multi-category engine (VEEV number one in Europe, growing oral) as reasons for confidence.
Calendar 2026 Q1
what gives you the confidence that Zen Ultra once it comes into the market, it can accelerate the growth again
Show response
CEO expressed confidence ZYN Ultra will match the most dynamic segments (higher nicotine, broader flavors) where ZYN currently lacks offerings. Noted ZYN offtake growth recently around 5-6%.
looking at the growth in Europe, around 5.5%. Is it a bit lower than what you were expecting
Show response
CEO pushed back, noting ex-Poland/Hungary flavor ban markets, Europe grew around 8%, in line with historical trends. Expected those markets to normalize in coming quarters.
the excise tax environment. We have seen some proposals from a few states planning to increase excise taxes
Show response
CEO argued differentiated taxation based on risk continuum, noting FDA views pouches as better alternatives to cigarettes. Declined to comment on specific state proposals until enacted.
PKGPackaging Corporation of America1 question · 1 reporting period · 0 of 1 challenging
Calendar 2026 Q1
anything in terms of overall industry demand for 2026, up 1%, 2% for the year
Show response
Mark declined to forecast industry demand. Tom confirmed PCA legacy demand running at about 4.5% with positive trends across key segments. Company only provides current-quarter outlook, not full-year industry projections.
Challenge rate by company
Every company this analyst questioned, most questions first. A company-level rate is shown from 3 questions; below that it is withheld.
| Company | Questions | Challenge rate |
|---|---|---|
| MO Altria | 4 | 25%1 of 4 questions |
| PM Philip Morris International | 4 | 25%1 of 4 questions |
| PKG Packaging Corporation of America | 1 | —Rate withheld: fewer than 3 questions |
Activity by reporting period
Questions recorded for each calendar quarter that companies’ reporting periods map to (not the call date), with the challenge rate for that period. Periods inside the range with no questions are shown as “No questions recorded”.
| Calendar period | Questions | Challenge rate | Companies |
|---|---|---|---|
| 2025 Q4 | 2 | 50%1 of 2 questions | 1 |
| 2026 Q1 | 4 | 25%1 of 4 questions | 2 |
| 2026 Q2 | 3 | 0%none of 3 questions | 2 |
- 2025 Q42 questions · challenge rate 50% (1 of 2 questions) · 1 company
- 2026 Q14 questions · challenge rate 25% (1 of 4 questions) · 2 companies
- 2026 Q23 questions · challenge rate 0% (none of 3 questions) · 2 companies
Topics
Topics tagged on this analyst’s questions.
- Demand4
- Product Launch3
- Regulation Policy2
- Competitive Dynamics2
- Pricing2
- Macroeconomic1
- Inventory1
- Revenue Growth1
- Geographic Expansion1